Equity Research Analyst’s Stock Ratings: Aytu BioScience, Inc. (AYTU), ToughBuilt Industries, Inc. (TBLT)

Aytu BioScience, Inc. (NASDAQ:AYTU) tinted gains of +2.38% (+0.04 points) to US$1.72. The volume of 0.21 Million shares climbed down over an trading activity of 952.33 Million shares. EPS ratio determined by looking at last 12 month figures is -7.14. Over the same time span, the stock marked US$12.8 as its best level and the lowest price reached was US$0.68. The corporation has a market cap of US$22.14 Million.

Aytu BioScience, Inc. (NASDAQ:AYTU)’s earnings per share has been growing at a 53.3 percent rate over the past 5 year when average revenue increase was noted as 361.4 percent. The return on equity ratio or ROE stands at -73.8 percent while most common profitability ratio return on investment (ROI) was -147 percent. The company’s institutional ownership is monitored at 8.5 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 51.4 percent gross margin.

Daily Analyst Recommendations

A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 2 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 0 think it is Hold. Recently, analysts have updated the overall rating to 1. 0 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.

ToughBuilt Industries, Inc. (NASDAQ:TBLT) is worth US$20.16 Million and has recently fallen 0% to US$1.62. The latest exchange of 0.27 Million shares is below its average trading activity of 1.44 Million shares. The day began at US$1.75 but the price moved to US$1.75 at one point during the trading and finally capitulating to a session high of US$1.8. The stock tapped a 52-week high of US$5.55 while the mean 12-month price target for the shares is US$0.

Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 0, and a price to sales ratio of 1.23. For the past 5 years, the company’s revenue has grown 0%, while the company’s earnings per share has grown 0%. With an institutional ownership near 16.07%, it carries an earnings per share ratio of -2.29.